Follow on Google News News By Tag * Cellular Screening * 3D tissue models * Phenotypic Drug Discovery * Cancer Immunotherapy * Organ On A Chip * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News |  Call for Speakers Now Open for CHI’s FAST: Functional Analysis & Screening Technologies CongressCHI, organizer of the 3rd Annual FAST: Functional Analysis & Screening Technologies Congress, has issued a call for papers for those who would like to present at its event on Nov. 9-11, 2015 in Boston, MA. Submission deadline is May 29, 2015.
By: Cambridge Healthtech Institute (CHI) November 9-10 Phenotypic Drug Discovery 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models November 10-11 Screening Strategies for Cancer Immunotherapy Screening and Functional Analysis of 3D Models CHI seeks high-quality papers related to the following topics: Assay development Target and pathway identification and validation Physiologically relevant models for phenotypic screening Data analysis for phenotypic screening High-content analysis Chemical genomics, chemical proteomics Quantitative systems pharmacology Co-culture cell models Complex cellular models of tumor microenvironment In vitro safety and efficacy assays for immunotherapy agents Physiologically relevant cellular assays for biologics Screening in primary cell models High-content screening of antibodies Cancer immunotherapy target discovery and validation Preclinical models for cancer immunotherapy studies In vitro models for cancer cell therapy development Assay development for 3D cell culture Use of primary and iPS cells in drug screening Organoid models for toxicity screening Bioprinting Tissue and stem cell organoid models Complex co-culture models Physiologically relevant spheroid models Organ-on-a-chip models 3D models of tumor microenvironment Tumor spheroid models for screening Tissue engineering applied to 3D models Assay development for screening 3D models High-content analysis of 3D models Functional analysis and target validation Screening multicellular tumor spheroid (MCTS) models HTS of 3D models for compound efficacy and safety profiling Phenotypic screening using 3D models Follow this link to submit a speaker proposal: http://www.fastcongress.com/ Submission Deadline is May 29, 2015. To inquire about sponsorship and exhibit opportunities, contact: Katelin Fitzgerald, Tel: 781-972-5458, kftizgerald@ About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, The Knowledge Foundation, and OpenHelix. http://www.chicorporate.com End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number